Question 1

What is HEXAMINOLEVULINATE HYDROCHLORIDE used for?

Accepted Answer

HEXAMINOLEVULINATE HYDROCHLORIDE (brand name Cysview) is a Electrolyte / Mineral indicated for 1 INDICATIONS AND USAGE Cysview is indicated for use in the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy.

Question 2

How does HEXAMINOLEVULINATE HYDROCHLORIDE work?

Accepted Answer

HEXAMINOLEVULINATE HYDROCHLORIDE works through the following mechanism: 12.1 Mechanism of Action Cysview is an ester of the heme precursor, aminolevulinic acid. After bladder instillation, Cysview enters the bladder mucosa and is proposed to enter the intracellular space of mucosal cells where it is used as a precursor in the formation of the photoactive intermediate protoporphyrin IX (PpIX) and other photoactive porphyrins (PAPs). PpIX and PAPs are reported to accumulate preferentially in neoplastic cells as compared to normal urothelium, partly due to altered enzymatic activity in the neoplastic cells. After excitation with light at wavelengths between 360 and 450 nm, PpIX and other PAPs return to a lower energy level by fluorescing, which can be detected and used for cystoscopic detection of lesions. The fluorescence from tumor tissue appears bright red and demarcated, whereas the background normal tissue appears dark blue. Similar processes may occur in inflamed cells..

Question 3

What are the most common side effects of HEXAMINOLEVULINATE HYDROCHLORIDE?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for HEXAMINOLEVULINATE HYDROCHLORIDE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is HEXAMINOLEVULINATE HYDROCHLORIDE the same as Cysview?

Accepted Answer

Cysview is a brand name for HEXAMINOLEVULINATE HYDROCHLORIDE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

HEXAMINOLEVULINATE HYDROCHLORIDE

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations